MY195679A - Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for use in the Treatment of Neurodegenerative Disorders - Google Patents

Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for use in the Treatment of Neurodegenerative Disorders

Info

Publication number
MY195679A
MY195679A MYPI2018002395A MYPI2018002395A MY195679A MY 195679 A MY195679 A MY 195679A MY PI2018002395 A MYPI2018002395 A MY PI2018002395A MY PI2018002395 A MYPI2018002395 A MY PI2018002395A MY 195679 A MY195679 A MY 195679A
Authority
MY
Malaysia
Prior art keywords
pyrazols
ylamino
pyrimidin
treatment
neurodegenerative disorders
Prior art date
Application number
MYPI2018002395A
Inventor
Anthony A Estrada
Joseph P Lyssikatos
Zachary K Sweeney
Vicente Fidalgo Javier De
Jianwen A Feng
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Priority claimed from PCT/US2017/037782 external-priority patent/WO2017218843A1/en
Publication of MY195679A publication Critical patent/MY195679A/en

Links

Abstract

The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof.
MYPI2018002395A 2016-11-03 2017-06-15 Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for use in the Treatment of Neurodegenerative Disorders MY195679A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662417151P 2016-11-03 2016-11-03
PCT/US2017/037782 WO2017218843A1 (en) 2016-06-16 2017-06-15 Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders
US201962350876P 2019-07-11 2019-07-11

Publications (1)

Publication Number Publication Date
MY195679A true MY195679A (en) 2023-02-03

Family

ID=87569417

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018002395A MY195679A (en) 2016-11-03 2017-06-15 Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for use in the Treatment of Neurodegenerative Disorders

Country Status (1)

Country Link
MY (1) MY195679A (en)

Similar Documents

Publication Publication Date Title
SA521430638B1 (en) Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for Use in The Treatment of Neurodegenerative Disorders
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
MX2021009673A (en) Modulators of ror-gamma.
CR20200054A (en) Compounds, compositions and methods
PH12017500583A1 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
PH12016501457A1 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
MD20170016A2 (en) Aminopyrimidinyl compounds as JAK inhibitors
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
PH12017500595B1 (en) Aldosterone synthase inhibitors
MX2016009621A (en) Furo-3-carboxamide derivatives and methods of use.
MY178971A (en) Triaminopyrimidine compounds useful for preventing or treating malaria
MX2020005707A (en) Creatine prodrugs, compositions and methods of use thereof.
MY195679A (en) Pyrimidin-2-Ylamino-1h-Pyrazols as Lrrk2 Inhibitors for use in the Treatment of Neurodegenerative Disorders
EA201892532A1 (en) Pyrimidine-2-Ilamino-1H-Pyrazoles as an LRRK2 inhibitor for use in the treatment of neurodegenerative diseases
MY183757A (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
NZ747201A (en) (+)-azasetron for use in the treatment of ear disorders